Department of General and Digestive Surgery, Hospital Doce de Octubre, Complutense University, 4ª Planta. Ctra Andalucía Km 5,4, 28041 Madrid, Spain.
World J Surg. 2013 Sep;37(9):2211-21. doi: 10.1007/s00268-013-2085-7.
The most practical measure to augment the available number of liver grafts and thus reduce waiting list mortality is to increase the donor age limit. We hypothesized that with careful selection of old liver donors without age limit it should be possible to obtain good patient and graft survival.
The present study comprises 351 adults who underwent liver transplantation. They were divided into three groups according to the age of the liver donors: group 1: 226 recipients of donors <60 years; group 2: 75 recipients of donors between 60 and 70 years; and group 3: 50 recipients of donors >70 years. A comparative study among the groups was performed.
Patient survival rates at 1, 3, and 5 years were, respectively, 81.0, 76.1, and 71.1 % in group 1; 83.8, 74, and 72.2 % in group 2; and 76, 70.0, and 62.9 % in group 3 (P = NS). Graft survival at 1, 3, and 5 years was, respectively, 74.8, 69.0, and 64.1 % in group 1; 82.7, 71.4, and 69.6 % in group 2; and 71.4, 64.8, and 58.3 % in group 3 (P = NS). We analyzed the use of older grafts in recipients with HCV cirrhosis and did not find significant differences in patient and graft survival at 1, 3, and 5 years. In multivariate analysis increased donor body mass index and decreased recipient albumin were associated with lower patient and graft survival.
Because patient and graft survival rates are not affected by donor age, well-selected older donor livers can be safely used if they show good function and preharvesting conditions.
增加可供移植的肝脏数量并降低等待名单死亡率的最实际措施是提高供者年龄上限。我们假设,如果仔细选择没有年龄限制的老年供者肝脏,应该可以获得良好的患者和移植物存活率。
本研究包括 351 名接受肝移植的成年人。他们根据供者的年龄分为三组:组 1:226 名接受<60 岁供者的患者;组 2:75 名接受 60-70 岁供者的患者;组 3:50 名接受>70 岁供者的患者。对三组患者进行了比较研究。
1、3、5 年的患者存活率分别为组 1:81.0%、76.1%和 71.1%;组 2:83.8%、74%和 72.2%;组 3:76%、70.0%和 62.9%(P=NS)。1、3、5 年的移植物存活率分别为组 1:74.8%、69.0%和 64.1%;组 2:82.7%、71.4%和 69.6%;组 3:71.4%、64.8%和 58.3%(P=NS)。我们分析了 HCV 肝硬化患者使用老年供肝的情况,并未发现 1、3、5 年患者和移植物存活率存在显著差异。多因素分析显示,供者体重指数增加和受者白蛋白减少与患者和移植物存活率降低相关。
由于患者和移植物存活率不受供者年龄影响,如果供者肝脏功能和术前状况良好,可安全使用经过精心挑选的老年供者肝脏。